Asian Biotechnology Conference BIO Asia to be held in Taiwan for the first time

TAIPEI, TAIWAN
-�Media OutReach - 10
April 2019 – The global Biotechnology Innovation
Organization (BIO) together with the Taiwan Bio Industry Organization (Taiwan
BIO) announced recently that from July 24th to 28th, a global Asian
biotechnology conference–BIO Asia-Taiwan 2019–will be held in Taipei. This
event, the result of a partnership between these two organizations and held in
Taiwan for the first time, is expected to attract more than 1,500 people from
25 countries. The exhibition meanwhile will increase in size from its previous
rendition as part of the annual ‘BioTaiwan’ event, to become what is expected
to be the largest biotech exhibition in Asia.

From left: William Foreman, President, AmCham Taipei
Liang-Gee Chen, Minister, Ministry of Science and Technology, Taiwan
Johnsee Lee, Chairman, BIO Asia-Taiwan Organizing Committee
Bor Fuei Huang, Secretary General , Taiwan Bio Industry Organization at the announcement ceremony of BIO Asia-Taiwan 2019

The announcement ceremony of BIO Asia-Taiwan 2019 was hosted by the Chairman of
the Organizing Committee, Johnsee Lee. Taiwan’s Minister of Science and
Technology Liang-gee Chen said in his remarks that BIO Asia being held in Taiwan is a
significant milestone and will be a positive contribution to the development of
Taiwan’s biomedical industry going forward. Chen expressed his wishes that
through the cooperation with BIO that there will be increased engagement and
interaction between Taiwan and the global biotechnology community. 

 
Jim Greenwood, President and CEO of BIO, the world’s largest biotech
association, in a videotaped message expressed his affirmation of Taiwan and
his expectations for this year’s event. “Taiwan is already a global powerhouse
in technology, IT and computing systems. As biotech evolves, we are marrying
new breakthroughs like artificial intelligence with Big Data derived from the
human genome. That’s why Taiwan is uniquely situated to play an integral role
in the future of our industry. Taiwan BIO’s annual conference is already an
established and important event for the local biotech community. Now we believe
BIO Asia-Taiwan will become a premier, must-attend conference for entire
Asia-Pacific region,” said Greenwood.

 
With the theme of this year’s event being “Biotech as the Next Growth
Engine for Asia”, Johnsee Lee remarked that as many innovative biomedical
advances in the future will be closely integrated with digital technologies,
and with the ICT industry being a unique advantage of Taiwan, this year’s BIO
Asia-Taiwan conference will showcase Taiwan’s digital advantage in this sector.
Applications such as AI, smart hospital and medical devices, precision
medicine, etc., will be showcased as Taiwan takes the opportunity to encourage
its electronics industry leaders to invest resources in biotech. Lee also
thanked the government for its strong support in facilitating the holding of
such a significant international conference.

 
Thanks to the support of BIO, participants in this year’s conference will be
utilizing BIO’s renowned one-to-one business partnering platform, creating
business opportunities for all participants. BIO also intends to use its vast
network of industry contacts to encourage international and regional
delegations to participate in the occasion. It is estimated that the numbers of
international exhibitors and delegates will increase significantly this year. With
the inclusion of a special program of medical seminars and training courses,
BIO Asia-Taiwan will also be targeting medical professionals and members of
biotechnology and medical associations. In addition, with the increasing
convergence of industry sectors, both Taiwan and global electronics, financial
and investment firms will be invited to discover opportunities at BIO
Asia-Taiwan.

 
The Conference & Forum program will feature pertinent business-related
topics such as cross-border investment, mergers and acquisitions, regional
cooperation models. Biomedical topics covered will include cancer
immunotherapy, cell and gene therapy, CAR-T, and regenerative medicine. The
latest game changing technologies featured will include artificial intelligence
(AI), Big Data, the Internet of Things, genetic sequencing, gene editing,
liquid biopsies, etc. International experts will be invited to give
presentations on such exciting topics and participate in these forums.

 
At the exhibition, we expect at least 1,700 booths featuring 600 exhibitors. In
addition to expanding its scale, the event this year will feature special
exhibition zones: International & Asia-Pacific Biotech; Smart Medical
Devices; Precision Medicine; Cell Therapy and Regenerative Medicine; and Innovation
& Enterprise. The exhibition venue will also feature a presentation theater
area, a business matchmaking venue, and a customized tour guide service.

 
“Biotech is very important to the American Chamber of Commerce, Taipei,
which has more than 500 member companies,” remarked William Foreman,
President of AmCham, Taipei. “There’s enormous potential in Taiwan for
this industry, and it’s important to host events such as BIO Asia-Taiwan that
attract leaders in the industry and give them a platform to exchange ideas. I
applaud BIO and Taiwan BIO for working so hard to create such an event,”
added Foreman in his remarks at the press conference.